Free Trial

MaxLinear, Inc $MXL Stock Holdings Lifted by Tudor Investment Corp ET AL

MaxLinear logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Tudor Investment Corp. boosted its stake in MaxLinear by 68.5% in Q3 to 427,195 shares (about $6.87M), representing roughly 0.49% of the company.
  • Insider activity: director Steven G. Litchfield sold 20,000 shares at $17.50 (part of 44,929 insider shares sold in the past 90 days); corporate insiders now own 7.80% of the stock while institutions own 90.79%.
  • Operational and market snapshot: MaxLinear beat Q results with EPS of $0.19 and revenue of $136.4M (up 48% y/y) but still shows a negative net margin and ROE; the consensus rating is a Hold with an average target of $19.57 and shares trading near $18.41.
  • Five stocks we like better than MaxLinear.

Tudor Investment Corp ET AL raised its position in shares of MaxLinear, Inc (NASDAQ:MXL - Free Report) by 68.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 427,195 shares of the semiconductor company's stock after purchasing an additional 173,709 shares during the quarter. Tudor Investment Corp ET AL owned 0.49% of MaxLinear worth $6,869,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Summit Global Investments purchased a new stake in shares of MaxLinear in the third quarter valued at $555,000. Lisanti Capital Growth LLC purchased a new stake in shares of MaxLinear in the third quarter valued at $1,180,000. AIGH Capital Management LLC purchased a new stake in shares of MaxLinear in the third quarter valued at $17,809,000. Essex Investment Management Co. LLC purchased a new stake in shares of MaxLinear in the third quarter valued at $3,864,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in shares of MaxLinear in the third quarter valued at $1,571,000. Hedge funds and other institutional investors own 90.79% of the company's stock.

Insider Buying and Selling at MaxLinear

In other news, insider Steven G. Litchfield sold 20,000 shares of the company's stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $17.50, for a total value of $350,000.00. Following the transaction, the insider directly owned 368,364 shares of the company's stock, valued at approximately $6,446,370. This represents a 5.15% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders have sold 44,929 shares of company stock valued at $746,456 over the last 90 days. Corporate insiders own 7.80% of the company's stock.

MaxLinear Trading Down 0.2%

NASDAQ MXL opened at $18.41 on Wednesday. MaxLinear, Inc has a 1-year low of $8.81 and a 1-year high of $20.82. The company has a current ratio of 1.34, a quick ratio of 0.92 and a debt-to-equity ratio of 0.27. The company has a market capitalization of $1.59 billion, a PE ratio of -11.65 and a beta of 1.70. The firm's fifty day simple moving average is $17.72 and its 200-day simple moving average is $17.12.

MaxLinear (NASDAQ:MXL - Get Free Report) last posted its quarterly earnings results on Thursday, January 29th. The semiconductor company reported $0.19 earnings per share for the quarter, topping analysts' consensus estimates of $0.18 by $0.01. MaxLinear had a negative net margin of 29.23% and a negative return on equity of 6.95%. The business had revenue of $136.44 million for the quarter, compared to the consensus estimate of $134.82 million. During the same period in the prior year, the business posted ($0.09) earnings per share. MaxLinear's revenue for the quarter was up 48.0% compared to the same quarter last year. As a group, sell-side analysts anticipate that MaxLinear, Inc will post -0.37 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the company. Benchmark increased their target price on MaxLinear from $25.00 to $28.00 and gave the company a "buy" rating in a report on Friday, January 16th. Wells Fargo & Company increased their target price on MaxLinear from $18.00 to $20.00 and gave the company an "equal weight" rating in a report on Friday, January 30th. Finally, Weiss Ratings restated a "sell (d-)" rating on shares of MaxLinear in a report on Thursday, January 22nd. Two investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, MaxLinear presently has a consensus rating of "Hold" and an average target price of $19.57.

Check Out Our Latest Stock Analysis on MXL

MaxLinear Company Profile

(Free Report)

MaxLinear, Inc is a provider of radio-frequency (RF), analog, and mixed-signal integrated circuits for broadband communications, data center connectivity, and video infrastructure applications. The company's product portfolio includes high-performance RF front-end modules, broadband power amplifiers, optical and Ethernet transceivers, and network processors designed to support demanding signal processing requirements.

MaxLinear's semiconductor solutions are used by cable and satellite television operators, fiber-to-the-home service providers, network equipment manufacturers, and data center operators.

Recommended Stories

Institutional Ownership by Quarter for MaxLinear (NASDAQ:MXL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in MaxLinear Right Now?

Before you consider MaxLinear, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MaxLinear wasn't on the list.

While MaxLinear currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines